FITB vs SLNO · P/E 17, rev $3.37B vs P/E 27, $2.76B cap
Fifth Third Bancorp (FITB) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
Fifth Third Bancorp (FITB) is a banks - regional company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported FITB revenue for 2026-06-30 was $3.37B. Net income was $801.0M. Revenue was up 13.5% from 2026-03-31 to 2026-06-30. FITB currently screens at market cap $45.25B and trailing P/E 16.8.
SLNO does not have a complete income-statement cache yet.
FITB currently screens at market cap $45.25B and trailing P/E 16.8. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the FITB and SLNO stock pages for the full models.
Not investment advice.